MARKET

AVGR

AVGR

Avinger
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.680
+0.080
+5.00%
Pre Market: 1.720 +0.04 +2.38% 05:39 03/02 EST
OPEN
1.680
PREV CLOSE
1.600
HIGH
1.715
LOW
1.630
VOLUME
704
TURNOVER
--
52 WEEK HIGH
2.670
52 WEEK LOW
0.2139
MARKET CAP
159.47M
P/E (TTM)
-1.2859
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
3 Penny Stocks For Your Watch List This Week If Biotech Is A Focus
Feb 24, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch Right Now If one grouping of penny stocks that've gained attention in the markets, it...
Penny Stocks · 5d ago
Laser Atherectomy Devices Market Size by Business Status 2021: Trends with Covid-19 Impact and Recovery, Growth Share, and Industry Revenue Forecast to 2025
Feb 22, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Laser Atherectomy Devices Market”...
The Express Wire · 02/22 06:59
AVGR, EBON, LODE and NXTD among midday movers
Gainers: Immunome (IMNM) +120%.Greenland Technologies (GTEC) +119%.Liberty TripAdvisor (LTRPB) +60%.Motus GI Holdings (MOTS) +35%.Charah Solutions (CHRA) +35%.Avinger (AVGR) +34%.VistaGen Therapeutics (VTGN) +32%.U.S. Well Services (USWS) +28%.Ebang Intern...
Seekingalpha · 02/18 17:40
Immunome, Avinger leads healthcare gainers; MEDNAX, ReWalk Robotics among major losers
Gainers: Immunome (IMNM) +93%, Avinger (AVGR) +33%, Titan Pharmaceuticals (TTNP) +17%, GBS (GBS) +15%, VistaGen Therapeutics (VTGN) +15%.Losers: MEDNAX (MD) -23%, ReWalk Robotics (RWLK) -21%, Shineco (TYHT) -19%, Check-Cap (CHEK) -15%, Advaxis (ADXS) -12%.
Seekingalpha · 02/18 16:01
Thinking about buying stock in Avinger, Rigel Pharmaceuticals, Vistagen Therapeutics, Bio-Path, or Corvus Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVGR, RIGL, VTGN, BPTH, and CRVS.
PR Newswire - PRF · 02/18 13:30
TWLO, RIGL, ONTX and MACK among premarket gainers
Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS)...
Seekingalpha · 02/18 13:26
Avinger surges on news of patent win
Avinger (AVGR) has added ~58.6% so far in the premarket on slightly below-average volume. There appears to be no company-specific news except social media chatter regarding a recent patent win secured by the firm.The
Seekingalpha · 02/18 13:03
Watching Avinger Shares After Hours As Traders Circulate US Patent & Trademark Office Feb. 10, 2021-Dated Application For Co.'s 'OPTICAL PRESSURE SENSOR ASSEMBLY'
https://patentcenter.uspto.gov/#!/applications/14776748
Benzinga · 02/17 22:14
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVGR. Analyze the recent business situations of Avinger through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVGR stock price target is 2.500 with a high estimate of 2.500 and a low estimate of 2.500.
EPS
Institutional Holdings
Institutions: 50
Institutional Holdings: 5.59M
% Owned: 5.89%
Shares Outstanding: 94.92M
TypeInstitutionsShares
Increased
9
990.86K
New
9
519.77K
Decreased
4
516.11K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+2.38%
Healthcare Equipment & Supplies
+2.12%
Key Executives
Chairman/Non-Executive Independent Director
James Cullen
President/Chief Executive Officer/Director
Jeffrey Soinski
Chief Financial Officer
Mark Weinswig
Chief Technology Officer
Himanshu Patel
Independent Director
Tamara Elias
Independent Director
James McElwee
  • Dividends
  • Splits
  • Insider Activity
No Data
About AVGR
Avinger, Inc., (Avinger) is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with the peripheral arterial disease (PAD). The Company manufactures and sells a suite of products in the United States and select international markets. Avinger’s products include its Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

Webull offers kinds of Avinger Inc stock information, including NASDAQ:AVGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVGR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVGR stock methods without spending real money on the virtual paper trading platform.